Healthcare
Do the New Obesity Drugs Pay for Themselves?
Could expensive drugs like Ozempic save healthcare systems money by reducing the risk of obesity-associated diseases? A new study co-authored by Yale SOM’s Jason Abaluck suggests that other health expenses may actually increase over the first couple years of treatment.
